A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Azure L. Yarbrough's research investigates the potential of cannabinoid receptors as therapeutic targets for cancer treatment, specifically focusing on Ewing sarcoma. Recent publications by Yarbrough and collaborators explore how natural and synthetic cannabinoids affect the viability of Ewing sarcoma cells, suggesting a mechanism involving non-canonical CB receptors. This work contributes to understanding the molecular underpinnings of cancer and exploring novel pharmacological interventions. Yarbrough's scholarly output includes 13 publications with 105 citations and an h-index of 5. Key collaborators at the University of Arkansas for Medical Sciences include Alicja Urbaniak, Amal Shoeib, Anna Radomińska‐Pandya, and Lirit N. Franks, with whom Yarbrough has co-authored multiple publications.
Metrics
- h-index: 5
- Publications: 13
- Citations: 105
Selected Publications
-
Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development (2021)
-
Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors (2021)
Collaboration Network
Top Collaborators
Amal Shoeib
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lori L. Hensley
Jacksonville State University (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Benjamin M. Ford
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lirit N. Franks
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Alicja Urbaniak
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Paul L. Prather
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Karol Kacprzak
Adam Mickiewicz University in Poznań (PL)
1 shared publication
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lance Benson
University of Arkansas for Medical Sciences (US)
1 shared publication
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
Shengyu Mu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
Similar Researchers
Based on overlapping research topics
Amal Shoeib
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Baku Acharya
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Cancer-related molecular mechanisms research
Tra Le
Arkansas State University
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
David P. Douglass
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Kerlin Balza
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies